Abstracts 2

  1. Development of lung and muscle protein factories to deliver therapeutic monoclonal antibodies
    Antepowicz A et al.,The British Society of Gene Therapy Annual Conference (2016)
  2. Delivery of Therapeutic Monoclonal Antibody Genes for Prophylaxis of Respiratory Syncytial Virus Infection.
    Antepowicz A et al.,The American Society of Gene and Cell Therapy Annual Conference (2017)

 

E.coli from a large scale industrial production of our clinical trial plasmid pGM169.